These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29489958)

  • 1. Does Parkinson's disease start in the gut?
    Gershanik OS
    Arq Neuropsiquiatr; 2018 Feb; 76(2):67-70. PubMed ID: 29489958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease.
    Rouaud T; Clairembault T; Coron E; Neunlist M; Anheim M; Derkinderen P
    Parkinsonism Relat Disord; 2017 Jul; 40():83-84. PubMed ID: 28483388
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.
    Montalbán-Rodríguez A; Abalo R; López-Gómez L
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut and Parkinson's Disease: Hype or Hope?
    Scheperjans F; Derkinderen P; Borghammer P
    J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.
    Del Tredici K; Braak H
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):33-50. PubMed ID: 26662475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort.
    Campagnolo M; Weis L; Sandre M; Tushevski A; Russo FP; Savarino E; Carecchio M; Stocco E; Macchi V; De Caro R; Parchi P; Bubacco L; Porzionato A; Antonini A; Emmi A
    Neurobiol Dis; 2024 Oct; 200():106609. PubMed ID: 39048026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
    Arotcarena ML; Dovero S; Prigent A; Bourdenx M; Camus S; Porras G; Thiolat ML; Tasselli M; Aubert P; Kruse N; Mollenhauer B; Trigo Damas I; Estrada C; Garcia-Carrillo N; Vaikath NN; El-Agnaf OMA; Herrero MT; Vila M; Obeso JA; Derkinderen P; Dehay B; Bezard E
    Brain; 2020 May; 143(5):1462-1475. PubMed ID: 32380543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linking for the analysis of α-synuclein in the enteric nervous system.
    Corbillé AG; Neunlist M; Derkinderen P
    J Neurochem; 2016 Dec; 139(5):839-847. PubMed ID: 27637918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A colonic biomarker of Parkinson's disease?
    Olanow CW
    Mov Disord; 2012 May; 27(6):674-6. PubMed ID: 22649001
    [No Abstract]   [Full Text] [Related]  

  • 13. Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.
    Anis E; Xie A; Brundin L; Brundin P
    Trends Endocrinol Metab; 2022 Feb; 33(2):147-157. PubMed ID: 34949514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
    Benvenuti L; D'Antongiovanni V; Pellegrini C; Antonioli L; Bernardini N; Blandizzi C; Fornai M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to: alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Gray MT; Gray DA; Woulfe JM
    Mov Disord; 2014 Aug; 29(9):1224-5. PubMed ID: 24930843
    [No Abstract]   [Full Text] [Related]  

  • 16. α-Synuclein and Lewy pathology in Parkinson's disease.
    Kalia LV; Kalia SK
    Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.
    Savitt D; Jankovic J
    Drugs; 2019 Jun; 79(8):797-810. PubMed ID: 30982161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
    Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like propagation of α-synuclein in the gut-brain axis.
    Chen Y; Shao Q; Yuan YH; Chen NH
    Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.